🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical study is to learn more about the effects of switc...
Status
Active Not Recruiting
Location
Be Well Medical Center
Start Date
2022-08-16
Trial ID
NCT05502341
Treatments Being Tested
Research Hypothesis: Administration of BMS-663068, a prodrug for HIV attach...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-11-23
Trial ID
NCT01009814
Treatments Being Tested
This 2-part study will determine the bioavailability of BMS-626529 in healt...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-08-03
Trial ID
NCT02508064
Treatments Being Tested
An oral dose in healthy subjects to determine the relative bioavailabilty o...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-08-12
Trial ID
NCT02859259
Treatments Being Tested
The RECOVER study is a self-controlled case series to evaluate whether the ...
Status
Active Not Recruiting
Location
Orlando Immunology Center
Start Date
2022-06-15
Trial ID
NCT05220358
Treatments Being Tested
The purpose of this study is to determine whether the BMS Attachment Inhibi...
Status
Active Not Recruiting
Location
GSK Investigational Site
Start Date
2015-02-23
Trial ID
NCT02362503
Treatments Being Tested
This randomized, open-label clinical trial will evaluate whether adding fos...
Status
Recruiting
Location
CR CHUM
Start Date
2025-09-30
Trial ID
NCT07030920
Treatments Being Tested
The purpose of this study is to assess the safety, efficacy, tolerability a...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-07-26
Trial ID
NCT01384734
Compassionate use access to fostemsavir (GSK3684934, formerly BMS-663068) f...
Status
Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04233047
Treatments Being Tested
This is a two-part study. Part 1 will evaluate relative bioavailability of ...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-03-05
Trial ID
NCT04757974
Treatments Being Tested